Synthesis and Antiproliferative Assay of 1,3,4-Oxadiazole and 1,2,4-Triazole Derivatives in Cancer Cells

12Citations
Citations of this article
13Readers
Mendeley users who have this article in their library.

Abstract

A series of new 1,3,4-oxadiazole and 1,2,4-triazole derivatives were synthesized. The structures were confirmed by IR, 1H-NMR, and MS. The compounds were evaluated for their antiproliferative activity against K562 (human erythromyeloblastoid leukemia cell line), MDA-MB-231 (human breast adenocarcinoma cell line), HT29 (human colon adenocarcinoma grade II cell line) and HepG2 (human hepatocellular liver carcinoma cell line) in vitro. The result showed that 7 compounds displayed inhibitory activities against K562 with the inhibition rate more than 50%. Especially, compound 5f exhibited the most potent activity against K562 with 85% inhibition ratio and could be used as lead compound to search new 1,3,4-oxadiazole derivatives as antiproliferative agent. © 2013, International Research and Cooperation Association for Bio & Socio-Sciences Advancement. All rights reserved.

Cite

CITATION STYLE

APA

Tu, G., Chen, X., Yan, Y., Lv, Q., Wang, J., & Li, S. (2013). Synthesis and Antiproliferative Assay of 1,3,4-Oxadiazole and 1,2,4-Triazole Derivatives in Cancer Cells. Drug Discoveries & Therapeutics, 7(2), 58–65. https://doi.org/10.5582/ddt.2013.v7.2.58

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free